Life at OSU

PORTLAND, Ore. – Patients with a prescription for an opioid use disorder medication may have a tough time getting it filled if their pharmacy is in a community that’s racially and economically segregated, according to a new study led by scientists at Oregon State University and Johns Hopkins University.

PORTLAND, Ore. – Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.

Researchers who work with tiny drug carriers known as lipid nanoparticles have developed a new type of material capable of reaching the lungs and the eyes, an important step toward genetic therapy for hereditary conditions like cystic fibrosis and inherited vision loss.

CORVALLIS, Ore. – Researchers have shown in a mouse model and lab cultures that a compound derived from hops reduces the abundance of a gut bacterium associated with metabolic syndrome.

PORTLAND, Ore. – Researchers in the Oregon State University College of Pharmacy have developed a drug delivery system that shows promise for greatly enhancing the efficacy of the medicine given to women with the life-threatening condition of ectopic pregnancy, which occurs when a fertilized egg implants somewhere other than the lining of the uterus.

David Bearden, interim dean of Oregon State University’s College of Pharmacy since December 2020, has been named dean of the college.

People recently released from prison in Oregon face a risk for opioid overdose 10 times greater than the general public, according to a new study led by an Oregon State University College of Pharmacy scientist.

PORTLAND, Oregon – A study by Oregon State University College of Pharmacy researchers suggests that two anticonvulsants often prescribed for chronic pain are only “modestly effective” at pain management and can create an unfavorable risk/reward situation for patients.

PORTLAND, Ore. – Oregon State University scientists have invented a way to make magnetic nanoparticles that get hotter than any previous nanoparticle, improving their cancer fighting ability.

PORTLAND, Oregon – Researchers at Oregon State University and Oregon Health & Science University have taken a key step toward improving and lengthening the lives of cystic fibrosis patients, who experience chronically clogged airways and a dramatically shortened life expectancy.